BAT Releases glo HYPER PRO in Bosnia and Herzegovina

BAT by 2FIRSTS.ai
Jun.21.2024
BAT Releases glo HYPER PRO in Bosnia and Herzegovina
British American Tobacco (BAT) launched its latest heated tobacco device, glo HYPER PRO, in Bosnia and Herzegovina on June 20th.

According to a report by Bljesak.Info on June 20th, British American Tobacco (BAT) unveiled its latest heated tobacco device, glo HYPER PRO, for the first time in Bosnia and Herzegovina.

 

Previously, glo HYPER PRO had been launched in Croatia, Serbia, Italy, Poland, Japan, and other countries. With the launch of glo HYPER PRO, BAT became the first tobacco company to offer all categories of smokeless products (including e-cigarettes, nicotine pouches, and the current glo HYPER PRO heated tobacco product) in the Bosnian market. The company claims that these are also important steps towards BAT's commitment to creating "A Better Tomorrow™" and realizing its vision of a smoke-free world. The company's strategic goal is to shift smokers from traditional tobacco products to lower-risk alternative products, with the aim of becoming the leading company in the smokeless industry by 2035.

 

Furthermore, BAT emphasized its significant contribution to the economy of Bosnia and Herzegovina. BAT has operations in the country, including corporate offices and iNovina, as well as over 400 iNovina kiosks nationwide. In addition, they directly employ over 1000 people in Bosnia and Herzegovina, providing more job opportunities for locals. In 2023, they contributed 336 million convertible marks (KM) to the national budget of Bosnia and Herzegovina.

 

BAT Bosnia and Herzegovina director Johan Baguca stated that

 

The glo HYPER PRO is not just a device, but a perfect combination of technological innovation and exquisite design. Its aim is to introduce new technologies, such as smart LED screens and the HeatBoost induction heating system... For us, the most important thing is the satisfaction of nearly nine million adult glo users worldwide. We believe that this device will be well-received in Bosnia and Herzegovina and will certainly further enhance our position as the only company in the industry to offer a full range of low-risk smoke-free products in the country.

 

The General Manager of BAT Adriatic Region, Zvonko Kolobara, stated

 

I am proud of the launch of our glo HYPER PRO device, which has fully encompassed the low risk product category in the entire Adriatic region market, including Bosnia and Herzegovina, within our BAT product line. This is crucial for BAT and our future business. The key is that we need to offer as wide a range as possible of lower risk alternative products for our consumers, adult smokers. Over the past three years, BAT has invested over 1.4 billion euros in research and development, commercialization, and scientific studies to support its portfolio of lower risk tobacco and nicotine products. These efforts are crucial, as clear regulatory frameworks are needed to differentiate between tobacco and lower risk products and understand the potential of these alternatives for adult smokers.

 

Currently, the glo HYPER PRO device is now available for purchase at iNovina newsstands and other retail locations in Bosnia and Herzegovina.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA and NIH Release New Wave 8 Restricted-Use PATH Study Data Files
FDA and NIH Release New Wave 8 Restricted-Use PATH Study Data Files
FDA’s Center for Tobacco Products and NIH’s National Institute on Drug Abuse announced that new Wave 8 restricted-use data files from the PATH Study are now available. The files contain data collected between January 2024 and December 2024, including questionnaire data, location characteristics data, and state identifier data.
Apr.17 by 2FIRSTS.ai
Special Report|Reynolds’ 337 Patent Case Ends, but a Harsher 337 Compliance Battle Now Targets the Entire Vape Supply Chain
Special Report|Reynolds’ 337 Patent Case Ends, but a Harsher 337 Compliance Battle Now Targets the Entire Vape Supply Chain
The U.S. International Trade Commission (ITC) has terminated Investigation 337-TA-1410 after invalidating key vape patent claims asserted by R.J. Reynolds Vapor Company, removing the immediate risk of import bans for dozens of companies. However, a new case—337-TA-1486—has already opened a more consequential legal front, shifting the focus from patent disputes to regulatory compliance across the vape supply chain, including PACT Act reporting, tax compliance, and FDA marketing authorization.
BAT
Mar.11
EU Novel Tobacco Regulation Trends and Business Response | Guest Contribution by a European Legal and Compliance Expert
EU Novel Tobacco Regulation Trends and Business Response | Guest Contribution by a European Legal and Compliance Expert
Carlos Cabrera, founder of CabLab Law & Advocacy, contributes this article to 2Firsts, arguing that the EU’s evolving approach to novel tobacco regulation may unintentionally reinforce cigarette use by narrowing alternatives. He warns companies to watch signals on flavours, labelling, traceability, nicotine pouch rules and digital marketing, while grounding business decisions in realistic timelines, compliance planning and continuous monitoring.
Apr.22
Belgium Calls for EU-Wide Limits on Vape Ingredients and Ban on Disposable E-Cigarettes
Belgium Calls for EU-Wide Limits on Vape Ingredients and Ban on Disposable E-Cigarettes
Belgian Health Minister Frank Vandenbroucke has called on the European Union to take stronger action on vaping, saying it is becoming an “epidemic” and accusing the industry of targeting young people.
Mar.26 by 2FIRSTS.ai
Special Report | Belarus Rejects Vape Ban, Opts for Tighter Market Controls
Special Report | Belarus Rejects Vape Ban, Opts for Tighter Market Controls
After weeks of debate over a potential blanket prohibition, Belarus has decided against banning electronic cigarettes, choosing instead to tighten control over wholesale, imports and licensing. President Alexander Lukashenko warned that an outright ban could drive the market underground and undermine state revenues, as officials move to curb widespread illicit trade while keeping retail sales largely intact.
Mar.04
KT&G Moves Ahead With Oral Nicotine Product Development and Pilot Line Preparation
KT&G Moves Ahead With Oral Nicotine Product Development and Pilot Line Preparation
According to a Korean media report, KT&G is developing a smokeless nicotine product that delivers nicotine through oral absorption and is preparing a pilot production line for research and development.
Apr.08 by 2FIRSTS.ai